OTC - ACTIVE INGREDIENT SECTION
Active ingredients: Purpose
Homosalate 8%, Octisalate 4%, Avobenzene 3%, Octocrylene 2% Sunscreen
Active ingredients: Purpose
Homosalate 8%, Octisalate 4%, Avobenzene 3%, Octocrylene 2% Sunscreen
Purpose
Uses Simultaneously protects skin, combats premature aging and moisturizes on contact
helps prevent sunburn
If used as directed with other sun protection measures (see directions), decreases the risk of skin cancer and early skin aging skin aging caused by the sun
Keep out of reach of children
Warnings
For external use only.
Do not use on damaged or broken skin
When using this product, keep out of of eyes.
Rinse with water to remove.
If swallowed, get medical help or contact a Poison Control Center right away.
Directions: Apply liberally 15 minutes before sun exposure
Use a water resistant sunscreen if swimming or sweating
Reapply at least every 2 hours
children under 6 months: ask a doctor
Sun Protection Measures: Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreenwith Broad Spectrum SPF value of 15 or higher and other sun protection measures including:
Limit time in the sun,especially from 10 a.m. -2p.m.
Wear long-sleeved shirts, pants, hats, and sunglasses
Inactive Ingredients Purified water (Aqua), Cyclometicone, Isostearyl Neopentanoate, Glycerin, Ceteareth-20, Polypropylene, Cetearyl Alcohol, Xanthan Gum, d-Panthenol, Octanohydroxamic acid, Caprylyl Glycol, Silica, Triacontanyl PVP, Cetyl Dimethicone, Ammonium Acryloyldimethyltaurate/VP Copolymer, PEG-40 Stearate, Tocopheryl, Disodium EDTA, Pentylene Glycol, Pantheyl Triacetate, Sodium Lactate, Lactic Acid, Serine, Urea, Sorbitol, Sodium Chloride, Allantoin, Oleyl Alcohol, Ethyl Linoleate.
Supergoop!
City Serum SPF 30
SPF 30
Broad Spectrum Sunscreen SPF 30 PA +++
2 fl. oz. / 60 ml.
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| f52be47f-7aa7-46c0-b1fa-50c18dd50206 | Product name | 1 | 20201029 |
| 444b3e50-f226-46ef-bfca-2e7035d140cd | Product name | 1 | 20190611 |
| 7cda52fc-125f-421c-8fea-bc1974370c49 | Product name | 2 | 20180703 |
| 0ca1d589-929b-4b33-bc5b-1d84abdafa6a | Product name | 1 | 20150324 |
| fc363c46-397b-4476-ac0f-70e43e8e4592 | Product name | 1 | 20150324 |
| 597b1cfd-7b31-5048-62be-ca5cd740da2f | Product name | 1 | 20140508 |
| ec2149b3-5c6d-5344-f757-c86411073075 | Product name | 1 | 20140508 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 75936-111-01 | City Sunscreen serum Broad Spectrum SPF 30Supergoop | 50 mL in 1 BOTTLE, PUMP | CREAM | 50 | 33 | |
| 75936-111-02 | City Sunscreen serum Broad Spectrum SPF 30Supergoop | 20 mL in 1 BOTTLE, PUMP | CREAM | 20 | 33 | |
| 75936-111-05 | City Sunscreen serum Broad Spectrum SPF 30Supergoop | 10 mL in 1 TUBE | CREAM | 10 | 33 | |
| 75936-111-06 | City Sunscreen serum Broad Spectrum SPF 30Supergoop | 60 mL in 1 TUBE | CREAM | 60 | 33 | |
| 75936-111-07 | City Sunscreen serum Broad Spectrum SPF 30Supergoop | 3 mL in 1 PACKET | CREAM | 3 | 33 | |
| 75936-111-08 | City Sunscreen serum Broad Spectrum SPF 30Supergoop | 15 mL in 1 TUBE | CREAM | 15 | 33 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| AVOBENZONE | ACTIVE INGREDIENT | G63QQF2NOX | 18 | |
| HOMOSALATE | ACTIVE INGREDIENT | V06SV4M95S | 18 | |
| OCTISALATE | ACTIVE INGREDIENT | 4X49Y0596W | 18 | |
| OCTOCRYLENE | ACTIVE INGREDIENT | 5A68WGF6WM | 18 | |
| AVOBENZONE | ACTIVE MOIETY | G63QQF2NOX | 18 | |
| HOMOSALATE | ACTIVE MOIETY | V06SV4M95S | 18 | |
| OCTISALATE | ACTIVE MOIETY | 4X49Y0596W | 18 | |
| OCTOCRYLENE | ACTIVE MOIETY | 5A68WGF6WM | 18 | |
| ALLANTOIN | INACTIVE INGREDIENT | 344S277G0Z | 18 | |
| CAPRYLYL GLYCOL | INACTIVE INGREDIENT | 00YIU5438U | 18 | |
| CYCLOMETHICONE | INACTIVE INGREDIENT | NMQ347994Z | 18 | |
| EDETATE DISODIUM | INACTIVE INGREDIENT | 7FLD91C86K | 18 | |
| ETHYL LINOLEATE | INACTIVE INGREDIENT | MJ2YTT4J8M | 18 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | 18 | |
| LACTIC ACID | INACTIVE INGREDIENT | 33X04XA5AT | 18 | |
| OLEYL ALCOHOL | INACTIVE INGREDIENT | 172F2WN8DV | 18 | |
| PANTHENOL | INACTIVE INGREDIENT | WV9CM0O67Z | 18 | |
| PENTYLENE GLYCOL | INACTIVE INGREDIENT | 50C1307PZG | 18 | |
| POLYOXYL 40 STEARATE | INACTIVE INGREDIENT | 13A4J4NH9I | 18 | |
| SERINE | INACTIVE INGREDIENT | 452VLY9402 | 18 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | 18 | |
| SODIUM CHLORIDE | INACTIVE INGREDIENT | 451W47IQ8X | 18 | |
| SODIUM LACTATE | INACTIVE INGREDIENT | TU7HW0W0QT | 18 | |
| SORBITOL | INACTIVE INGREDIENT | 506T60A25R | 18 | |
| UREA | INACTIVE INGREDIENT | 8W8T17847W | 18 | |
| XANTHAN GUM | INACTIVE INGREDIENT | TTV12P4NEE | 18 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 75936-111 | 75936-111-01, 75936-111-02, 75936-111-05, 75936-111-06, 75936-111-07, 75936-111-08 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| CYCLOMETHICONE | NMQ347994Z | IACT |
| GLYCERIN | PDC6A3C0OX | IACT |
| XANTHAN GUM | TTV12P4NEE | IACT |
| PANTHENOL | WV9CM0O67Z | IACT |
| CAPRYLYL GLYCOL | 00YIU5438U | IACT |
| SILICON DIOXIDE | ETJ7Z6XBU4 | IACT |
| POLYOXYL 40 STEARATE | 13A4J4NH9I | IACT |
| EDETATE DISODIUM | 7FLD91C86K | IACT |
| PENTYLENE GLYCOL | 50C1307PZG | IACT |
| SODIUM LACTATE | TU7HW0W0QT | IACT |
| LACTIC ACID | 33X04XA5AT | IACT |
| SERINE | 452VLY9402 | IACT |
| UREA | 8W8T17847W | IACT |
| SORBITOL | 506T60A25R | IACT |
| SODIUM CHLORIDE | 451W47IQ8X | IACT |
| ALLANTOIN | 344S277G0Z | IACT |
| OLEYL ALCOHOL | 172F2WN8DV | IACT |
| ETHYL LINOLEATE | MJ2YTT4J8M | IACT |
| HOMOSALATE | V06SV4M95S | ACTIB |
| OCTISALATE | 4X49Y0596W | ACTIB |
| AVOBENZONE | G63QQF2NOX | ACTIB |
| OCTOCRYLENE | 5A68WGF6WM | ACTIB |
| Version | Effective date | Source | Hydrated |
|---|---|---|---|
| 32 | 2022-10-20 | full-release | 2026-05-31 23:51:07 |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| ALLANTOIN | ALLANTOIN | 344S277G0Z | GEL / TOPICAL | 8 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | GEL / TOPICAL | 6 mg | ||
| SERINE | SERINE | 452VLY9402 | INJECTION, SOLUTION / INTRAVENOUS | 0.18 %w/v | ||
| CYCLOMETHICONE | CYCLOMETHICONE | NMQ347994Z | CREAM / TOPICAL | 13 %w/w | ||
| UREA | UREA | 8W8T17847W | SYSTEM / TOPICAL | 840 mg | ||
| UREA | UREA | 8W8T17847W | SYSTEM / TOPICAL | 840 mg | ||
| ALLANTOIN | ALLANTOIN | 344S277G0Z | GEL / TOPICAL | 8 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | CREAM / TOPICAL | 0.4 %w/w | ||
| POLYOXYL 40 STEARATE | POLYOXYL 40 STEARATE TYPE I | 13A4J4NH9I | CREAM / TOPICAL | 86000 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | CREAM / TOPICAL | 0.4 %w/w | ||
| SORBITOL | SORBITOL | 506T60A25R | CREAM / TOPICAL | 36.8 %w/w | ||
| CYCLOMETHICONE | CYCLOMETHICONE | NMQ347994Z | CREAM / TOPICAL | 13 %w/w | ||
| ALLANTOIN | ALLANTOIN | 344S277G0Z | GEL / TOPICAL | 8 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | CREAM / VAGINAL | 51 mg | ||
| CYCLOMETHICONE | CYCLOMETHICONE | NMQ347994Z | CREAM / TOPICAL | 13 %w/w | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | GEL / TOPICAL | 6 mg | ||
| LACTIC ACID | LACTIC ACID | 33X04XA5AT | CREAM / TOPICAL | 1 %w/w | ||
| UREA | UREA | 8W8T17847W | CREAM / VAGINAL | 0.64 %w/w | ||
| SODIUM LACTATE | SODIUM LACTATE | TU7HW0W0QT | SOLUTION / TOPICAL | 0.93 %w/w | ||
| OLEYL ALCOHOL | OLEYL ALCOHOL | 172F2WN8DV | CREAM / TOPICAL | 10 %w/w | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | CREAM / TOPICAL | 14 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | GEL / TOPICAL | 6 mg | ||
| SERINE | SERINE | 452VLY9402 | INJECTION, SOLUTION / INTRAVENOUS | 0.18 %w/v | ||
| UREA | UREA | 8W8T17847W | SYSTEM / TOPICAL | 840 mg | ||
| UREA | UREA | 8W8T17847W | SYSTEM / TOPICAL | 840 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | GEL / TOPICAL | 6 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | CREAM / TOPICAL | 0.4 %w/w | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | CREAM / TOPICAL | 14 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CREAM / TOPICAL | 1720 mg | ||
| SERINE | SERINE | 452VLY9402 | INJECTION / INTRAVENOUS | 0.5 %w/v | ||
| OLEYL ALCOHOL | OLEYL ALCOHOL | 172F2WN8DV | CREAM / TOPICAL | 10 %w/w | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | CREAM / TOPICAL | 14 mg | ||
| SERINE | SERINE | 452VLY9402 | INJECTION, SOLUTION / INTRAVENOUS | 0.18 %w/v | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | CREAM / VAGINAL | 51 mg | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | CREAM / TOPICAL | 46 mg | ||
| UREA | UREA | 8W8T17847W | SYSTEM / TOPICAL | 840 mg | ||
| OLEYL ALCOHOL | OLEYL ALCOHOL | 172F2WN8DV | CREAM / TOPICAL | 10 %w/w | ||
| UREA | UREA | 8W8T17847W | SYSTEM / TOPICAL | 840 mg | ||
| SERINE | SERINE | 452VLY9402 | INJECTION / INTRAVENOUS | 0.5 %w/v | ||
| SODIUM LACTATE | SODIUM LACTATE | TU7HW0W0QT | GEL / TOPICAL | 4 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | CREAM / TOPICAL | 14 mg | ||
| ALLANTOIN | ALLANTOIN | 344S277G0Z | GEL / TOPICAL | 8 mg | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | CREAM / TOPICAL | 46 mg | ||
| SODIUM LACTATE | SODIUM LACTATE | TU7HW0W0QT | SOLUTION / TOPICAL | 0.93 %w/w | ||
| OLEYL ALCOHOL | OLEYL ALCOHOL | 172F2WN8DV | CREAM / TOPICAL | 10 %w/w | ||
| POLYOXYL 40 STEARATE | POLYOXYL 40 STEARATE TYPE I | 13A4J4NH9I | CREAM / TOPICAL | 86000 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | CREAM / VAGINAL | 51 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | CREAM / TOPICAL | 14 mg | ||
| SODIUM LACTATE | SODIUM LACTATE | TU7HW0W0QT | GEL / TOPICAL | 4 mg | ||
| SODIUM LACTATE | SODIUM LACTATE | TU7HW0W0QT | GEL / TOPICAL | 4 mg | ||
| ALLANTOIN | ALLANTOIN | 344S277G0Z | GEL / TOPICAL | 8 mg | ||
| UREA | UREA | 8W8T17847W | CREAM / VAGINAL | 0.64 %w/w | ||
| SERINE | SERINE | 452VLY9402 | INJECTION, SOLUTION / INTRAVENOUS | 0.18 %w/v | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | GEL / TOPICAL | 6 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | CREAM / TOPICAL | 14 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | CREAM / VAGINAL | 51 mg | ||
| SORBITOL | SORBITOL | 506T60A25R | CREAM / TOPICAL | 36.8 %w/w | ||
| SODIUM LACTATE | SODIUM LACTATE | TU7HW0W0QT | GEL / TOPICAL | 4 mg | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | CREAM / TOPICAL | 46 mg | ||
| UREA | UREA | 8W8T17847W | CREAM / VAGINAL | 0.64 %w/w |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| City Sunscreen serum Broad Spectrum SPF 30 Supergoop | HOMOSALATE, OCTISALATE, AVOBENZENE, OCTOCRYLENE | Supergoop, LLC | 61766f7b-512d-45b5-b652-e09975a3d3fc | 2026-01-09 | Warnings | 75936-111-05 75936-111-06 75936-111-02 75936-111-07 75936-111-01 75936-111-08 75936-111 75936011101 75936011106 75936011105 75936011107 75936011102 75936011108 47f8490a-7781-8eda-e063-6294a90ade01 61766f7b-512d-45b5-b652-e09975a3d3fc |
Adverse event summaries are temporarily unavailable. Other product information remains available.